Showing results (571-580 of 31,426) with videos related to

Sort By:
Pageof 3,143
Antimicrobial Agents and Chemotherapy|December 29, 2011
Influence of soil use on prevalence of tetracycline, streptomycin, and erythromycin resistance and associated resistance genesMagdalena Popowska, Marzenna Rzeczycka, Antoni Miernik, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2011
First report of the multidrug resistance gene cfr in Enterococcus faecalis of animal originYang Liu, Yang Wang, Congming Wu, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2011
A novel agent effective against Clostridium difficile infectionSofya Dvoskin, Wei-Chu Xu, Neal C Brown, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2011
Efficacy of sitafloxacin-based rescue therapy for Helicobacter pylori after failures of first- and second-line therapiesJuntaro Matsuzaki, Hidekazu Suzuki, Toshihiro Nishizawa, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2011
Identification of novel N-(morpholine-4-carbonyloxy) amidine compounds as potent inhibitors against hepatitis C virus replicationAkiko Kusano-Kitazume, Naoya Sakamoto, Yukiko Okuno, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2011
Reshuffling of Aspergillus fumigatus cell wall components chitin and β-glucan under the influence of caspofungin or nikkomycin Z alone or in combinationPatricia E B Verwer, M L van Duijn, M Tavakol, et al.
Antimicrobial Agents and Chemotherapy|March 28, 2012
Safety and tolerability of voriconazole in patients with baseline renal insufficiency and candidemiaA M L Oude Lashof, J D Sobel, M Ruhnke, et al.
Antimicrobial Agents and Chemotherapy|March 28, 2012
Class A carbapenemase FPH-1 from Francisella philomiragiaMarta Toth, Viktoria Vakulenko, Nuno T Antunes, et al.
Antimicrobial Agents and Chemotherapy|April 4, 2012
Pharmacokinetic/Pharmacodynamic predictors of clinical potency for hepatitis C virus nonnucleoside polymerase and protease inhibitorsMicaela B Reddy, Peter N Morcos, Sophie Le Pogam, et al.
Pageof 3,143